cas12117-sup-0001-FigS1.tifimage/tif171KFig. S1. Drug sensitivities to gefitinib, erlotinib and SU11274 under sorting nexin (SNX) 1 knockdown. (A) Effect of SNX1 knockdown by SNX1 siRNA, as determined using immunoblotting. (B) Effect of SNX1 knockdown on expression of c-Met and EGFR in EBC-1 and PC-9 cells, as determined using immunoblotting. (C–E) Drug sensitivity of SNX1 siRNA-treated EBC-1 and PC-9 cells to gefitinib (C), erlotinib (D) and SU11274 (E), as determined using a cell viability assay.
cas12117-sup-0002_SupportingFigurelegend.docxWord document14K 

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.